SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $57,000 | +216.7% | 290 | +81.2% | 0.02% | +212.5% |
| Q4 2019 | $18,000 | +28.6% | 160 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $14,000 | +7.7% | 160 | -15.8% | 0.01% | 0.0% |
| Q2 2019 | $13,000 | -7.1% | 190 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $14,000 | +7.7% | 190 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $13,000 | -18.8% | 190 | -9.5% | 0.01% | -12.5% |
| Q3 2018 | $16,000 | +14.3% | 210 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $14,000 | +16.7% | 210 | -8.7% | 0.01% | +14.3% |
| Q1 2018 | $12,000 | 0.0% | 230 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $12,000 | -99.9% | 230 | -32.4% | 0.01% | -41.7% |
| Q3 2017 | $18,499,000 | +5.2% | 340 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $17,592,000 | -16.4% | 340 | 0.0% | 0.01% | -15.4% |
| Q1 2017 | $21,043,000 | +105115.0% | 340 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $20,000 | +42.9% | 340 | 0.0% | 0.01% | +44.4% |
| Q2 2016 | $14,000 | +133.3% | 340 | +112.5% | 0.01% | +125.0% |
| Q1 2016 | $6,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 19,322,947 | $846,925,000 | 12.04% |
| CAPITAL GUARDIAN TRUST CO | 6,585,072 | $288,624,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,521,388 | $66,682,000 | 1.38% |
| CAPITAL INTERNATIONAL LTD /CA/ | 477,400 | $20,924,000 | 1.37% |
| USS Investment Management Ltd | 1,658,954 | $72,712,000 | 1.36% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 7,547,000 | $330,785,000 | 1.33% |
| Baillie Gifford | 9,811,312 | $430,030,000 | 1.09% |
| Princeton Portfolio Strategies Group LLC | 32,800 | $1,438,000 | 1.06% |
| ROCKEFELLER FINANCIAL SERVICES INC | 1,028,318 | $45,072,000 | 1.05% |
| WASATCH ADVISORS LP | 2,148,869 | $94,185,000 | 0.98% |